Differential expression of Aquaporin 8 in human colonic epithelial cells and colorectal tumors
© Fischer et al; licensee BioMed Central Ltd. 2001
Received: 4 December 2000
Accepted: 23 January 2001
Published: 23 January 2001
The gene expression pattern in tumor cells differs from that in corresponding normal cells. In order to identify differentially expressed genes in colorectal tumors and normal colorectal epithelium, a differential display experiment was used to compare RNA expression in normal and tumor tissue samples.
One gene fragment was expressed only in normal tissue and not, or to a much lesser extent, in the adenomas, carcinomas and cancer cell lines. The isolated gene fragment was identical to Aquaporin 8 (AQP8), a water channel protein. In situ hybridization demonstrated that AQP8 was expressed in the cells facing the lumen in the normal colonic epithelium.
Our result suggests that the expression of AQP8 is a marker of normal proliferating colonic epithelial cells and suggest these cells to be involved in fluid transport in the colon.
Many genes are known to be involved in colorectal carcinogenesis. Colorectal cancer is sometimes inherited in familial syndromes like Familial Adenomatous Polyposis (FAP) or Hereditary Nonpolyposis Colorectal Cancer (HNPCC) . The identification of the predisposing genes in inherited tumors have meant great contribution to our understanding of colorectal carcinogenesis in these families but also of carcinogenesis in general . The majority of colorectal tumors, however, are sporadic, and studies in sporadic tumors have revealed other genes of importance in colorectal tumor development, e.g. K-Ras , TGFβ , E-cadherin , SRC  and the PPARγ . Genes may be altered in tumors compared to normal tissue without necessarily being causative. Tumor cells often de-differentiate or have their origin in immature cell types and loose expression of proteins associated with highly differentiated cells, and could in stead gain expression of embryonic proteins. These alterations can potentially be used as clinical markers to define a particular disease entity, useful for diagnosis, staging, population screening or even to detect the presence of occult metastatic disease, recurrent disease and response to treatment. The perhaps most known embryonic protein used as a tumor marker in malignancy is the CEA in colorectal cancer . In an attempt to identify additional genes altered during the development of colorectal cancer, we compared the gene expression pattern between normal colon epithelium samples and colorectal tumors using the mRNA differential display PCR (mRNA DD-PCR) method. In this paper we report that the water channel protein AQP8 is expressed in the normal columnar epithelial cells of the colonic mucosa facing lumen and that adenomas and colorectal cancer do not seem to express this protein.
One gene fragment of approximately 80 bp was expressed in the 4 normal tissue samples but not, or to a much lesser degree, in 24 colorectal tumors in the mRNA DD-PCR experiment. The band was cut and reamplified using the same primers, and cloned. Clones were then selected by size, and by using inverse northern hybridization it was found that all clones represented the same DNA sequence. Sequencing and subsequent search in the genome database showed that this differentially expressed gene fragment corresponded to the sequence of aquaporin 8 (AQP8).
To study what cells expressed the AQP8 mRNA, in situ hybridization was used. In samples from 2 normal colonic mucosa there was a staining of mRNA AQP8 expression in the columnar surface epithelium only (Fig. 3a). No expression of AQP8 was detected in any of one sporadic rectal carcinoma, one sporadic colon carcinoma or one HNPCC carcinoma tested (the HNPCC carcinoma is shown)(Fig. 3c). The RNA in situ experiment suggested that only normal mucosa expressed AQP8.
In total 15 colon cancer cell lines, six microsatellite unstable (SW48, LOVO, HT116, RKO, LS174T, DDL1) and 9 microsatellite stable (SW480, SW620, HT29, CACO2, Crl7184, Crl7456, Crl2405, 238CCL, 233CCL), were tested for expression of AQP8 using RT-PCR. None of them demonstrated expression of the AQP8 transcript, supporting the hypothesis that tumor cells do not express AQP8 (Fig. 4).
This study was designed to detect additional genes altered during colorectal carcinogenesis. One of the genes found, AQP8, was expressed in all normal colon samples but not, or to a less extent, in the colorectal tumors. The expression of AQP8 in tumor samples in Figure 2 can be explained in two ways. It is possible that adenomas and cancer cells do not express AQP8 in these samples and that the PCR products results from normal cell contamination. Alternatively it is possible that adenomas can develop in a cell already differentiated to express AQP8. The known function of this gene and the in situ hybridization result from this study suggest this protein to be a marker of fully differentiated epithelial cells. In the maturation process of cells from the colonic crypt, the stem cells differentiate to become either goblet cell in the crypt or surface epithelial cell . This experiment suggests that the expression of AQP8 is limited to the differentiated mature columnar epithelial cells. None of the cell types in the crypt, including the stem cells seemed to express AQP8 in our in situ experiment. Tumors did not express AQP8. The reason for this can be that this gene has been downregulated in tumorigenes. Another, perhaps more likely, explanation could be that tumors arise in immature cells. There are other proteins whose expression is of late appearance in the life cycle of a colonic crypt cell, like the epthelial Na+ conductance channel ENaC  and maxi K+ channels , which could have been picked up by this experiment similar to AQP8. The reason why they were not picked could be related to the fact that using a limited number of primers not all differentially expressed genes will show up. Furthermore, since these genes are mostly expressed in distal colon cells, and not in proximal colon cells they would not have been identified by us as differentially expressed between normal and tumor tissue and therefore not selected for further studies.
Aquaporins (AQP) are members of the major intrinsic super family of integral membrane proteins, which act as specialized channels to facilitate the passage of water through the cell membrane in animals, plants, and bacteria. So far 10 AQP homologues named from 0 to 9 have been cloned in mammals. They are widely distributed and more than one AQP could be present in the same cell . Several human AQP genes have been cloned and an increasing number of disturbances have been found associated to the abnormal function of these proteins . The human AQP8 gene was cloned in 1998 and was shown to be important for cell fluid transport . Expression of the gene was demonstrated by northern blot in human pancreatic and colonic tissue .
Our finding of AQP8 expression in human columnar surface epithelial cells, suggests these cells to be involved in water resorption in human colon. Since mRNA-in situ hybridization showed a positive signal for mRNA expression of AQP8 in the normal columnar surface epithelial cells and no signal from the cells in the crypt (Fig. 3), this indicates that the expression of AQP8 is a marker only of fully differentiated surface colonic epithelial cells.
Materials and Methods
Tumors and cell lines
mRNA differential display RT-PCR (mRNA DD-PCR) was run on a panel of 24 fresh frozen colorectal tumors and 4 normal colon mucosa tissue (collected at the Umeå hospital 1987-1991). All tumors were at stage Dukes´ B. For the expression study with RT-PCR and Northern blot, we used the same tumors as above plus another 3 normal colonic tissues, 7 sporadic colorectal carcinomas, 5 sporadic adenomas (collected at Umeå Hospital 1987-1991) and 3 HNPCC tumors (collected at Karolinska Hospital, Stockholm). The RNA in situ study used samples from the above-described tissues. From all patients samples were obtained immediately after surgery and frozen at -70°C. The cell lines SW48, LOVO, HT116, RKO, LS174T, DDL1, SW480, SW620, HT29, CACO2, Crl7184, Crl7456, Crl2405, 238CCL, and 233CCL were cultured in Dulbecco´s modified Eagle´s medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum (Gibco), 100 U/ml penicillin (Gibco), and 100 μg/ml streptomycin (Gibco) in 90 mm tissue culture plates (Falcon).
RNA and DNA preparation
Total RNA was extracted from frozen tissue by homogenizing with a power homogenizer (IKA Labortechnik) in Trizol Reagent due to manufacturer's protocol (Life Technologies) and used for mRNA DD-PCR, RT-PCR, and northern blot. The RNA was treated with deoxyribonuclease I (Ambion Inc).
mRNA Differential Display RT-PCR (mRNA DD-PCR) was performed essentially according to the method of Liang and Pardee, using the one base anchoring primer [17,18]. Primers were synthesized by Genset Oligos. Anchoring primer for the AQP8 fragment was 5'-AAGCT11C-3' and the arbitrary primer was 5'-AAG CTT TTA CCG C-3'. Band was cut and reamplified with the same primers and then cloned without purification in a TA-vector (PCR II, Invitrogen). Clones were selected by size, followed by inverse hybridization . DNA was sequenced with Thermo sequenase radiolabeled terminator cycle sequencing kit (Pharmacia & Amersham). Homology searches were performed using Blast search in GenBank databases.
Primers designed for the isolated fragments were used on template from tumors and normal colonic tissue for comparison of expression. In a volume of 40 μl, 2 μg total RNA was reverse transcribed with the following conditions: 5 mM MgCl2, 50 mM KCL, 10 mM Tris-HCl, pH 8.3, 1 mM dNTP´s, 1 U RNase inhibitor (Perkin Elmer), 2.5 U MuLV Reverse transcriptase (Perkin Elmer).
The PCR reaction volume was 25 μl containing 500 nM of each primer, 250 nM of DNTP´s, and 2.5 U of ampliTaq (Gibco, Life Technologies). cDNA was diluted 1:20 in water and 10 μl of the same dilution were used for all samples and controls. The primers used were as follows for AQP8 1200r 5'-AAA TGG GGT GCG GGA AAT GAG-3', aqp8f 800 5'-CCT GCT TG TTG GAC TGC TC-3', and aqp8f 150f 5'-TGG CGA GTG TCC TGG TAC-3'. Glyceraldehyde-3-phosphate dehydrogenase was used as internal control with the primers: F 5'-GAA GGC TGG GGC TCA TTT G-3' and R 5'-GAT GGC ATG GAC TGT GGT CA-3'. Thermocycler (PTC 225, Mj Research) was used with an initial denaturation step of 94°C for 2 min, followed by cycles of 94°C for 45 s, 59°C for 30 s, 72°C for 30 s, and a final elongation step of 72°C for 5 min. PCR products amplified after 25, 30, and 35 cycles were separated on a 1.5% agarose gel containing ethidium bromide for comparison between samples and controls.
10 μg total RNA from 3 normal colonic tissues, 2 HNPCC carcinomas, 3 sporadic colon carcinomas and 2 colon cancer cell lines, was separated by size using electrophoresis on 1.5% denaturing agarose gel. The RNA was transferred to a nylon plus membrane (Qiabrane, Qiagen). The membrane was UV-crosslinked and prehybridization and hybridization was as described . A 600 bp gel-purified PCR fragment generated with primer 5'-TGT TTG CAC TGC TCT CTG G-3' and 5'-AAA TGG GGT GCG GGA AAT GT-3' was 32P-labeled with a random primer labelling kit (redi prime DNA labelling system; Pharmacia & Amersham) and used as a probe. The blot was reprobed with radiolabelled β-actin cDNA (Clontech) as loading control. Filters were analyzed with PhosphorImager (Fujix 1000)
RNA-in situ hybridization
Consecutive frozen tissue sections were taken from two normal colonic mucosa tissues, one sporadic colonic cancer, one sporadic rectal cancer and one HNPCC cancer. Fourteen μm sections were cut at -18°C in a cryostat (Jung CM 3000, Leica Instrument). One section was processed for RNA-in situ hybridization and the next was stained with Hematoxylin and Eosin (H&E). In situ RNA hybridization was performed as described previously . About 40 bp oligonucleotides from base pairs 165-205 were synthesized as sense and antisense (GeneSet oligos) and used as probes.
The Swedish Cancer Foundation, The Cancer Foundation in Stockholm and The Lion's Cancer Research Foundation in Umeå supported this work. The authors would like to thank Susanne Petersson for valuable advice.
- Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell. 1996, 87: 159-70. 10.1016/S0092-8674(00)81333-1.View ArticlePubMed
- Kressner U, Bjorheim J, Westring S, Wahlberg SS, Pahlman L, Glimelius B, Lindmark G, Lindblom A, Borresen-Dale AL: Ki-ras mutations and prognosis in colorectal cancer. Eur J Cancer. 1998, 34: 518-21. 10.1016/S0959-8049(97)10111-3.View ArticlePubMed
- Brattain MG, Markowitz SD, Willson JK: The type II transforming growth factor-beta receptor as a tumor-suppressor gene. Current Opinion in Oncology. 1996, 8: 49-53.View ArticlePubMed
- Christofori G, Semb H: The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci. 1999, 24: 73-6. 10.1016/S0968-0004(98)01343-7.View ArticlePubMed
- Irby RB, Mao W, Coppola D, Kang J, Loubeau JM, Trudeau W, Karl R, Fujita DJ, Jove R, Yeatman TJ: Activating SRC mutation in a subset of advanced human colon cancers. Nature Genetics. 1999, 21: 187-90. 10.1038/5971.View ArticlePubMed
- Sarraf P, Mueller E, Smith WM, Wright HM, Kum JB, Aaltonen LA, de la Chapelle A, Spiegelman BM, Eng C: Loss-of-function mutations in PPAR gamma associated with human colon cancer. Molecular Cell. 1999, 3: 799-804. 10.1016/S1097-2765(01)80012-5.View ArticlePubMed
- Ewing HP, Newsom BD, Hardy JD: Tumor markers. Curr Probl Surg. 1982, 19: 53-94.View ArticlePubMed
- Karam SM: Lineage commitment and maturation of epithelial cells in the gut. Frontiers in Bioscience. 1999, 4: D286-98.View ArticlePubMed
- Garty H, Palmer LG: Epithelial sodium channels: function, structure, and regulation. Physiol Rev. 1997, 77: 359-96.PubMed
- Grunnet M, Knaus HG, Solander C, Klaerke DA: Quantification and distribution of Ca(2+)-activated maxi K(+) channels in rabbit distal colon. Am J Physiol. 1999, 277: G22-30.PubMed
- Echevarria M, Ilundain AA: Aquaporins. J Physiol Biochem. 1998, 54: 107-18.PubMed
- Koyama N, Ishibashi K, Kuwahara M, Inase N, Ichioka M, Sasaki S, Marumo F: Cloning and functional expression of human aquaporin8 cDNA and analysis of its gene. Genomics. 1998, 54: 169-72. 10.1006/geno.1998.5552.View ArticlePubMed
- Naftalin RJ, Pedley KC: Regional crypt function in rat large intestine in relation to fluid absorption and growth of the pericryptal sheath. Journal of Physiology. 1999, 514: 211-27. 10.1111/j.1469-7793.1999.211af.x.PubMed CentralView ArticlePubMed
- Koyama Y, Yamamoto T, Kondo D, Funaki H, Yaoita E, Kawasaki K, Sato N, Hatakeyama K, Kihara I: Molecular cloning of a new aquaporin from rat pancreas and liver. J Biol Chem. 1997, 272: 30329-33. 10.1074/jbc.272.48.30329.View ArticlePubMed
- Ma T, Verkman AS: Aquaporin water channels in gastrointestinal physiology. J Physiol (Lond). 1999, 517: 317-26. 10.1111/j.1469-7793.1999.0317t.x.View Article
- Ramirez-Lorca R, Vizuete ML, Venero JL, Revuelta M, Cano J, Ilundain AA, Echevarria M: Localization of aquaporin-3 mRNA and protein along the gastrointestinal tract of Wistar rats. Pflugers Archiv - European Journal of Physiology. 1999, 438: 94-100. 10.1007/s004240050884.View ArticlePubMed
- Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992, 257: 967-71.View ArticlePubMed
- Liang P, Pardee AB: Recent advances in differential display. Curr Opin Immunol. 1995, 7: 274-80. 10.1016/0952-7915(95)80015-8.View ArticlePubMed
- Utans U, Liang P, Wyner LR, Karnovsky MJ, Russell ME: Chronic cardiac rejection: identification of five upregulated genes in transplanted hearts by differential mRNA display. Proceedings of the National Academy of Sciences of the United States of America. 1994, 91: 6463-7.PubMed CentralView ArticlePubMed
- Sambrook J, Fritsch EF, Maniatis Y: Molecular cloning; a laboratory manual. Second Edition. Cold Spring Harbor Laboratory Press,. 1989
- Sandberg Nordqvist AC, von Holst H, Holmin S, Sara VR, Bellander BM, Schalling M: Increase of insulin-like growth factor (IGF)-1, IGF binding protein-2 and -4 mRNAs following cerebral contusion. Brain Research. Molecular Brain Research. 1996, 38: 285-93. 10.1016/0169-328X(95)00346-T.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.